Index
-
Market Cap
331.67M
Enterprise Value
359.10M
Income
-59.52M
Sales
205.31M
Book/sh
1.04
Cash/sh
0.70
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
450
IPO
Apr 23, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
1.62
P/B
4.91
P/C
7.27
P/FCF
-
EV/EBITDA
-
EV/Sales
1.75
Quick Ratio
1.95
Current Ratio
2.90
Debt/Eq
1.08
LT Debt/Eq
1.02
Option/Short
Yes / Yes
EPS (ttm)
-0.93
EPS next Y
-0.77
EPS next Q
-0.25
EPS this Y
8.60%
EPS next Y
8.94%
EPS next 5Y
9.18%
EPS past 3/5Y
-6.38% -61.76%
Sales past 3/5Y
14.46% 29.96%
EPS Y/Y TTM
-17.90%
Sales Y/Y TTM
-3.95%
EPS Q/Q
11.63%
Sales Q/Q
-4.24%
Insider Own
26.71%
Insider Trans
2.52%
Inst Own
49.01%
Inst Trans
-9.68%
ROA
-30.72%
ROE
-71.99%
ROIC
-43.48%
Gross Margin
79.45%
Oper. Margin
-26.17%
Profit Margin
-28.99%
SMA20
19.96%
SMA50
14.92%
SMA200
57.46%
Trades
Shs Outstand
65.24M
Shs Float
47.67M
52W High
6.65 -23.31%
52W Low
1.17 335.90%
Volatility
6.45% 5.89%
ATR (14)
0.30
RSI (14)
71.77
Beta
1.60
Rel Volume
0.08
Avg Volume
284.12K
Volume
1,160
Perf Week
19.44%
Perf Month
17.78%
Perf Quarter
8.97%
Perf Half Y
174.19%
Perf YTD
108.16%
Perf Year
-19.69%
Perf 3Y
-47.29%
Perf 5Y
-77.88%
Perf 10Y
-
Prev Close
5.06
Price
5.10
Change %
0.79%
Analysts 9 incl. previous ratings
Rating Distribution 2 Buy · 6 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Nov 07, 2025 Downgrade J JP Morgan
Neutral → Underweight $5 -2.0% Nov 07, 2025 Downgrade B BTIG Research
Buy → Neutral Feb 04, 2025 Upgrade B BTIG Research
Neutral → Buy $16 +213.7% Dec 31, 2024 Initiated L Lake Street
Buy $14.50 +184.3% Dec 17, 2024 Resumed J JP Morgan
Neutral $8 +56.9% May 16, 2024 Downgrade U UBS
Buy → Neutral $16 → $6.50 +27.5% May 08, 2024 Downgrade T Truist
Buy → Hold $17 → $7 +37.3% May 08, 2024 Downgrade S Stifel
Buy → Hold $15 → $6 +17.6% May 08, 2024 Downgrade M Morgan Stanley
Overweight → Equal-Weight $15 → $5.50 +7.8% May 08, 2024 Downgrade J JP Morgan
Overweight → Neutral $15 → $8 +56.9% May 08, 2024 Downgrade B BTIG Research
Buy → Neutral Sep 29, 2023 Initiated U UBS
Buy $24 +370.6% May 01, 2023 Initiated T Truist
Buy $33 +547.1% Apr 11, 2023 Initiated S Stephens
Equal-Weight $26 +409.8% May 12, 2022 Initiated B BTIG Research
Buy $22 +331.4% Jan 07, 2022 Upgrade M Morgan Stanley
Equal-Weight → Overweight $30 +488.2% May 18, 2021 Initiated S SVB Leerink
Outperform $38 +645.1% May 18, 2021 Initiated S Stifel
Buy $35 +586.3% May 18, 2021 Initiated M Morgan Stanley
Equal-Weight $30 +488.2% May 18, 2021 Initiated J JP Morgan
Overweight $37 +625.5%
Show Previous Ratings
Oct-29-26 03:18PM
Oct-23-26 07:05AM
Sep-26-26 12:43AM
Sep-17-26 05:16PM
Sep-15-26 05:06PM
03:00PM
Loading…
Aug-07-26 03:00PM
07:14AM
07:05AM
Aug-06-26 09:20AM
Jul-24-26 02:24PM
07:05AM
Jun-18-26 07:05AM
Jun-16-26 10:00AM
Jun-11-26 04:05PM
May-09-26 03:02AM
07:19AM
Loading…
May-08-26 07:19AM
07:05AM
May-07-26 09:20AM
Apr-24-26 07:05AM
Apr-07-26 09:04AM
Feb-27-26 02:00PM
11:47AM
07:18AM
(Associated Press Finance)
07:05AM
Feb-26-26 07:22AM
Feb-24-26 10:45PM
07:05AM
Feb-12-26 05:13PM
Feb-09-26 02:15PM
Jan-13-26 07:05AM
04:05PM
Loading…
Jan-08-26 04:05PM
Dec-30-25 04:05PM
Dec-18-25 08:30AM
Nov-07-25 08:05AM
Nov-06-25 05:40PM
04:34PM
(Associated Press Finance)
04:05PM
Nov-05-25 07:50AM
Oct-23-25 04:05PM
Sep-10-25 07:05AM
Aug-08-25 09:01PM
Aug-07-25 06:05PM
05:03PM
(Associated Press Finance)
04:05PM
04:01PM
Aug-05-25 04:05PM
Aug-04-25 05:35PM
Jul-24-25 04:05PM
Jun-05-25 01:00PM
May-30-25 05:45AM
May-13-25 09:55AM
May-09-25 11:55AM
10:15AM
(Thomson Reuters StreetEvents)
05:45AM
03:43AM
May-08-25 06:15PM
05:22PM
(Associated Press Finance)
04:05PM
May-07-25 06:55PM
11:55AM
10:54AM
May-06-25 08:35AM
Apr-25-25 05:45AM
Apr-24-25 04:05PM
Apr-18-25 05:45AM
Apr-07-25 10:08AM
08:00AM
Mar-28-25 02:00PM
Mar-25-25 04:15PM
Feb-28-25 07:24AM
(Thomson Reuters StreetEvents)
02:40AM
Feb-27-25 06:25PM
05:28PM
(Associated Press Finance)
04:05PM
Feb-26-25 08:02AM
Feb-06-25 04:15PM
Feb-04-25 03:17PM
Jan-30-25 08:00AM
Jan-13-25 08:00AM
Jan-02-25 04:15PM
Dec-30-24 08:15AM
Dec-19-24 07:37AM
Dec-16-24 08:30AM
Dec-04-24 04:15PM
Dec-02-24 04:15PM
Nov-18-24 04:46PM
Nov-06-24 10:09AM
(Thomson Reuters StreetEvents)
+35.07%
02:22AM
Nov-05-24 05:25PM
04:21PM
(Associated Press Finance)
04:05PM
Nov-04-24 05:29PM
08:00AM
07:12AM
07:00AM
Oct-22-24 04:30PM
Oct-14-24 09:45AM
Oct-09-24 05:08PM
Sep-18-24 10:53AM
Sep-11-24 08:00AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Treace John T. Chief Executive Officer Aug 20 '26 Buy 4.44 39,944 177,176 7,388,383 Aug 24 05:00 PM Treace John T. Chief Executive Officer Aug 24 '26 Buy 4.34 11,000 47,731 7,404,383 Aug 24 05:00 PM Treace John T. Chief Executive Officer Aug 21 '26 Buy 4.35 5,000 21,748 7,393,383 Aug 24 05:00 PM Treace John T. Chief Executive Officer Jun 10 '26 Buy 4.02 29,430 118,426 7,353,263 Jun 11 04:52 PM Treace John T. Chief Executive Officer Jun 11 '26 Buy 4.04 22,887 92,541 7,376,150 Jun 11 04:52 PM Treace John T. Chief Executive Officer Jun 01 '26 Buy 3.56 50,000 177,915 7,323,833 Jun 01 04:38 PM Treace John T. Chief Executive Officer May 28 '26 Buy 3.02 61,202 184,824 7,273,833 May 28 04:33 PM Treace John T. Chief Executive Officer May 27 '26 Buy 2.87 49,810 143,189 7,212,631 May 28 04:33 PM Treace John T. Chief Executive Officer May 26 '26 Buy 2.79 4,508 12,576 7,162,821 May 28 04:33 PM Treace John T. Chief Executive Officer May 14 '26 Buy 2.62 61,750 161,495 7,158,313 May 14 05:33 PM Treace John T. Chief Executive Officer May 13 '26 Buy 2.46 49,013 120,533 7,096,563 May 14 05:33 PM Treace John T. Chief Executive Officer May 12 '26 Buy 2.17 43,000 93,478 7,047,550 May 14 05:33 PM Scanlan Sean F. Chief Innovation Officer Feb 10 '26 Option Exercise 1.05 16,875 17,719 706,474 Feb 11 09:00 PM Scanlan Sean F. Chief Innovation Officer Jan 21 '26 Option Exercise 0.72 53,500 38,520 427,099 Jan 23 09:30 PM
Treace Medical Concepts, Inc. engages in the designing, manufacturing, and marketing of orthopedic medical devices and biologic solutions. The firm offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
Founder Mr. John T. Treace
Chief Financial Officer Mr. Mark L. Hair CPA
Chief Legal & Compliance Officer and Corporate Secretary Mr. Scot M. Elder J.D.
Chief Innovation & Marketing Officer Dr. Sean F. Scanlan Ph.D.
Chief Operations & Supply Chain Officer Mr. Terry W. Lubben